Recombinant DNA technologies developed in the early 1970s enabled scientists to isolate genes of interest and splice them into existing DNA structures. However, as late as the early 1980s, the ...

A huge budget increase proposed by the president. Numerous legislative initiatives at the federal and state level. Public fears of biological harm. That is the new reality brought to us by ...

In a recent study posted to the bioRxiv* preprint server, researchers developed a human endogenous retrovirus (HERV)-enveloped recombinant baculoviral deoxyribonucleic acid (DNA) vaccine to target the ...

The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...

With the aim of streamlining the regulatory process for biopharmaceutical manufacturers engaged in vaccine, recombinant DNA, ...